Author(s): Jayprakash. S. Suryawanshi, Shivaji. P. Gawade

Email(s): jay.suryawanshi79@gmail.com

DOI: 10.5958/0974-360X.2020.00662.9   

Address: Jayprakash. S. Suryawanshi1*, Shivaji. P. Gawade2
1Department of Pharmacognosy, Satara College of Pharmacy, Satara, Maharashtra, India-415004.
2LNBC Institute of Pharmacy, Raigaon, Satara, Maharashtra, India- 415005.
*Corresponding Author

Published In:   Volume - 13,      Issue - 8,     Year - 2020


ABSTRACT:
In the present study an effort was made to evaluate the comparative clinical significance of Mustard oil (Brassica juncea) and its nanoemulgel formulation in clinically diagnosed patients of rheumatoid arthritis (RA). Different nanoemulsions were prepared on the basis of pseudoternary phase diagrams using aqueous titration method. The gel matrix was prepared using Carbapol 934 and optimized nanoemulsion was added to obtain the nanoemulgel. Wistar albino rats were used for skin irritation study of nanoemulgel. The mustard oil was prepared as per its traditional approach and the comparative clinical study of mustard oil and its nanoemulgel formulation was carried out. The formulation didn’t exhibit any edema to exposed rat skin and found safe to be used for human skin. In clinical study, nanoemulgel was found to be significant (p<0.001***) in every parameter of assessment compared to oil. It had significantly reduced the joint pain, inflammation and stiffness. As far as hematological changes concerned, the nanoemulgel had lowered the raised ESR value significantly in all the patients but failed to modify other blood parameters. The results revealed that mustard oil nanoemulgel formulation can be used as a possible substitute to conventional formulation of oil with enhanced permeation characters for topical application.


Cite this article:
Jayprakash. S. Suryawanshi, Shivaji. P. Gawade. Enhanced anti-arthritic effect of mustard oil in Nanoemulgel Formulation: A comparative clinical study. Research J. Pharm. and Tech. 2020; 13(8):3738-3744. doi: 10.5958/0974-360X.2020.00662.9

Cite(Electronic):
Jayprakash. S. Suryawanshi, Shivaji. P. Gawade. Enhanced anti-arthritic effect of mustard oil in Nanoemulgel Formulation: A comparative clinical study. Research J. Pharm. and Tech. 2020; 13(8):3738-3744. doi: 10.5958/0974-360X.2020.00662.9   Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-8-35


REFERENCES:
1.    Cotran R. S., Kumar, V. and Collins T. Robinson pathologic basis of disease 6th Ed, Philadelphia 1999.
2.    Arthritis Foundation. Arthritis by the Numbers, Book of Trusted Facts and Figures; v2; 4100.17.10445, 2018.
3.    Shah P, Bhalodia D, Shelat P. Nanoemulsion: A Pharmaceutical Review, Sys Rev Pharm.2010; Vol.1, 4-32.
4.    Vinod Ade and Dhirajsingh Rajput Management of Amavata (Rheumatoid Arthritis) by application of Ayurvedic principle, International Journal of Research in Ayurveda and Pharmacy. 2007; 8 (4), 134-138.
5.    Shakeel, F., Baboota, S., Ahuja, A., Ali, J., Aqil, M., and Shafiq, S. Nanoemulsions as vehicles for transdermal delivery of Aceclofenac. AAPS Pharmscitech. 2007; 8(4), 191.
6.    Musthaba S. M., Baboota, S., Ahmed, S., Ahuja, A., and Ali, J. Status of novel drug delivery technology for phytotherapeutics. Expert Opinion on Drug Delivery.2009; 6(6), 625-637.
7.    Chellapa, P., Mohamed, A. T., Keleb, E. I., Elmahgoubi, A., Eid, A. M., Issa, Y. S., and Elmarzugi, N. A. Nanoemulsion and nanoemulgel as a topical formulation. IOSR J Pharm. 2015; 5, 2250-3013.
8.    Dhawan B, Geeta A. and Harikumar S. Enhanced transdermal permeability of Piroxicam through novel nanoemulgel formulation. International Journal of Pharmaceutical Investigation. 2017; 4, no. 2: 65.
9.    Bhattacharya S. and Prajapati B. G. Formulation and Optimization of Celecoxib Nanoemulgel. Asian Journal of Pharmaceutical and Clinical Research. 2017 10(8), 353-365.
10.    Pund S., Pawar S., Gangurde S., and Divate D. Transcutaneous delivery of Leflunomide nanoemulgel: Mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity. International Journal of Pharmaceutics. 2015; 487(1-2), 148-156.
11.    Verma S., Singh A. K., and Mukerjee A. Formulation and evaluation of Ketoconazole nanoemulgel. World Journal of Pharmacy and Pharmaceutical Sciences.2015; 5 (2), 899-911.
12.    Mahtab A., Anwar M., Mallick N., Naz Z., Jain G. K., and Ahmad F. J. Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS Pharm Sci Tech.2016; 17(6), 1477-1490.
13.    Bhavprakash Nighantu-Indian Materia Medica of Shri Bhav Mishra, Chaukhambha Bharati Academy, Varanasi, India, 655-656,1999.
14.    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum.1988; 31(3):315-24.
15.    Khurana S., Jain N. K., and Bedi P.M. Nanoemulsion based Gel for Transdermal Delivery of Meloxicam: physico-chemical, mechanistic investigation. Life sciences.2013; 92(6-7), 383-392.
16.    Bhatia A., Singh B., Raza K., Wadhwa S., and Katare O. P. Tamoxifen-loaded Lecithin organogel (LO) for topical application: development, optimization and characterization. International Journal of Pharmaceutics.2013; 444(1-2), 47-59.
17.    Fransen J., Stucki G., and van Riel P. L. Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score‐28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Care and Research: Official Journal of the American College of Rheumatology.2003; 49(S5), S214-S224.
18.    Marpaung B., and Siregar J. Effect of Sidaguri (Sidarhombifolia L) on C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in osteoarthritis patients. In IOP Conference Series: Earth and Environmental Science. 2018; (Vol. 125, No. 1, p. 012188). IOP Publishing.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available